Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-24

Clinical Trial Update: MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 clinical trial evaluating MELAtonin for the prevention of postoperative agitation and emergence delirium in children, currently in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Emergence Delirium | Phase 3 | Status: RECRUITING